| 2025-08-14 |
详情>>
股本变动：
变动后总股本3815.23万股
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益0.76美元,归母净利润2205.26万美元,同比去年增长243.13%
|
| 2025-08-08 |
详情>>
业绩披露：
2024年年报每股收益-37.69美元,归母净利润-1亿美元,同比去年增长-204.59%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.02美元,归母净利润-47.68万美元,同比去年增长95.47%
|
| 2025-04-03 |
复牌提示：
2025-04-03 10:27:47 停牌，复牌日期 2025-04-03 16:24:00
|
| 2025-01-23 |
股东大会：
将于2025-03-11召开股东大会
会议内容 ▼▲
- 1.To approve the issuance of all common shares that may be issued upon the exercise of pre-funded warrants to purchase common shares, series A warrants to purchase common shares (the “December Series A Warrants”) and series B warrants to purchase common shares (the “December Series B Warrants”) that were issued to certain purchasers on December 16, 2024, which, for the avoidance of doubt, includes all common shares that may be issued as a result of any (i) voluntary adjustment by the Company, from time to time, of the exercise price of any and all outstanding December Series A Warrants and December Series B Warrants pursuant to the terms of the December Series A Warrants and the December Series B Warrants, respectively, (ii) adjustment to the exercise price and number of common shares underlying the December Series A Warrants and the December Series B Warrants in the event of a Share Combination Event (as defined in the December Series A Warrants and the December Series B Warrants), (iii) adjustment to the exercise price and number of common shares underlying the December Series A Warrants and the December Series B Warrants following the Reset Date (as defined in the December Series A Warrants and the December Series B Warrants), (iv) adjustment to the exercise price and number of common shares underlying the December Series A Warrants and the December Series B Warrants following a Dilutive Issuance (as defined in the December Series A Warrants and the December Series B Warrants), or (iv) alternative cashless exercise pursuant to Section 2.3 of the December Series A Warrants, as well as to fully implement the adjustments contemplated by the definition of the “Floor Price” contained in the December Series A Warrants and the December Series B Warrants.
2.To approve certain adjustments to the series A warrants to purchase common shares (the “October Series A Warrants”) and the series B warrants to purchase common shares (the “October Series B Warrants”) that were issued to certain purchasers on October 30, 2024, which includes (i) an adjustment to the exercise price and the Floor Price (as defined in the October Series A Warrants) of the outstanding October Series A Warrants to $0.81 (subject to adjustments for stock splits, stock combinations, recapitalizations and similar transactions), and a corresponding increase to the number of common shares underlying the October Series A Warrants so that the aggregate exercise value shall remain unchanged, and (ii) an adjustment to the exercise price and the Floor Price (as defined in the October Series B Warrants) of the outstanding October Series B Warrants to $0.54 (subject to adjustments for stock splits, stock combinations, recapitalizations and similar transactions), and a corresponding increase to the number of common shares underlying the October Series B Warrants so that the aggregate exercise value shall remain unchanged.
3.To approve Amendment No. 4 to the Second Amended and Restated Operating Agreement of the Company to increase the number of authorized common shares to 2,000,000,000 shares.
4.To approve Amendment No. 3 to the 1847 Holdings LLC 2023 Equity Incentive Plan to increase the share reserve to 5,000,000 common shares.
5.To approve the adjournment of the Special Meeting to a later date if necessary to solicit additional proxies if there are not sufficient votes to approve any of the foregoing proposals at the time of the Special Meeting, or any adjournment or postponement thereof.
|
| 2024-11-19 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-393.13美元,归母净利润-1264.97万美元,同比去年增长-11.58%
|
| 2024-11-05 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2024-08-19 |
详情>>
业绩披露：
2024年中报每股收益-39.7美元,归母净利润-1540.75万美元,同比去年增长-187.71%
|
| 2024-07-01 |
详情>>
拆分方案：
每13.0000合并分成1.0000股
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-4.38美元,归母净利润-1052.4万美元,同比去年增长-1088.71%
|
| 2024-04-29 |
股东大会：
将于2024-06-25召开股东大会
会议内容 ▼▲
- 1.To elect the seven nominees named in the accompanying proxy statement to the board of directors, each to serve until our next annual meeting of shareholders or until such person shall resign, be removed or otherwise leave office.
2.To ratify the appointment of Sadler, Gibb & Associates, LLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
3.To approve Amendment No. 1 to the 1847 Holdings LLC 2023 Equity Incentive Plan to increase the share reserve.
4.To approve Amendment No. 2 to the 1847 Holdings LLC 2023 Equity Incentive Plan to add an evergreen provision.
5.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-04-25 |
详情>>
业绩披露：
2023年年报每股收益-90.1美元,归母净利润-3291.61万美元,同比去年增长-63.99%
|
| 2024-04-15 |
详情>>
内部人交易：
Roberts Ellery股份增加42379.00股
|
| 2024-01-08 |
详情>>
拆分方案：
每4.0000合并分成1.0000股
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-14.01美元,归母净利润-1133.66万美元,同比去年增长23.41%
|
| 2023-09-11 |
详情>>
拆分方案：
每25.0000合并分成1.0000股
|
| 2023-09-08 |
股东大会：
将于2023-10-10召开股东大会
会议内容 ▼▲
- 1.To approve the issuance of common shares upon the conversion of promissory notes and the exercise of warrants issued to certain investors.
2.To approve the adjournment of the Special Meeting to a later date if necessary to solicit additional proxies if there are not sufficient votes to approve the foregoing proposal at the time of the Special Meeting, or any adjournment or postponement thereof.
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-1.04美元,归母净利润-535.53万美元,同比去年增长-293.49%
|
| 2023-08-14 |
财报披露：
美东时间 2023-08-14 盘后发布财报
|
| 2023-05-16 |
详情>>
业绩披露：
2023年一季报每股收益-0.2美元,归母净利润-88.53万美元,同比去年增长12.19%
|
| 2023-04-11 |
股东大会：
将于2023-05-09召开股东大会
会议内容 ▼▲
- 1.To elect the six (6) nominees identified in the accompanying Proxy Statement to serve as directors on the Board of Directors (the “Board”) for the ensuing year.
2.To ratify the appointment of Sadler, Gibb & Associates, LLC as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
3.To have an advisory vote on the compensation of our named executive officers.
4.To have an advisory vote on the frequency of advisory votes on the compensation of our named executive officers.
5.To approve the issuance of common shares upon the conversion of promissory notes and the exercise of warrants issued to certain investors.
6.To approve our 2023 Equity Incentive Plan.
7.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|